Daniel J. Drucker
33Patents
17h-index
7Co-inventors
70Inventor score
Filing activity: Apr 14, 1995 → Jul 25, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6184201A | Intestinotrophic glucagon-like peptide-2 analogs | Human Necessities | 87 | Expired |
| US5834428A | Glucagon-like peptide-2 and its therapeutic use | Chemistry; Metallurgy | 85 | Expired |
| US6890898B2 | Method of regulating glucose metabolism, and reagents related thereto | Human Necessities | 84 | Expired |
| US5789379A | Glucagon-like peptide-2 analogs | Human Necessities | 80 | Expired |
| US5990077A | Glucagon-like peptide-2 and its therapeutic use | Physics | 79 | Expired |
| US5846937A | Method of using exendin and GLP-1 to affect the central nervous system | Human Necessities | 76 | Expired |
| US6803357B1 | Method of regulating glucose metabolism, and reagents related thereto | Human Necessities | 75 | Expired |
| US6051557A | Methods of enhancing functioning of the upper gastrointestinal tract | Human Necessities | 54 | Expired |
| US5952301A | Compositions and methods for enhancing intestinal function | Human Necessities | 42 | Expired |
| US7049284B2 | Glucagon-like peptide-2 and its therapeutic use | Chemistry; Metallurgy | 38 | Expired |
| US6723530B1 | Polynucleotides encoding proexendin, and methods and uses thereof | Chemistry; Metallurgy | 31 | Expired |
| US6586399B1 | Methods of enhancing functioning of the large intestine | Chemistry; Metallurgy | 31 | Expired |
| US5994500A | Antagonists of intestinotrophic GLP-2 peptides | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7829530B2 | Method of regulating glucose metabolism, and reagents related thereto | Human Necessities | 22 | Active |
| US6297214A | Methods of enhancing functioning of the large intestine | Chemistry; Metallurgy | 22 | Expired |
| US6489295B1 | Antagonists of intestinotrophic GLP-2 peptides | Emerging Cross-Sectional Technologies | 17 | Expired |
| US7176182B2 | Methods of enhancing functioning of the large intestine | Chemistry; Metallurgy | 17 | Expired |
| US7157429B1 | Method of regulating glucose metabolism, and reagents related thereto | Human Necessities | 15 | Expired |
| US7078381B2 | Method of regulating glucose metabolism, and reagents related thereto | Human Necessities | 14 | Expired |
| US7459428B2 | Method of regulating glucose metabolism, and reagents related thereto | Human Necessities | 6 | Active |
| US7642241B2 | Methods of enhancing functioning of the large intestine | Chemistry; Metallurgy | 5 | Active |
| US7960344B2 | Methods of enhancing functioning of the large intestine | Chemistry; Metallurgy | 3 | Active |
| US9044424B2 | Methods of regulating glucose metabolism, and reagents related thereto | Human Necessities | 2 | Active |
| US7888317B2 | Glucagon-like peptide-2 and its therapeutic use | Chemistry; Metallurgy | 2 | Active |
| US8318669B2 | Method of regulating glucose metabolism, and reagents related thereto | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.